Breaking News

Tweet TWEET

Achillion to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference

Achillion to Present at the Noble Financial Capital Markets' Ninth Annual
Equity Conference

NEW HAVEN, Conn., Jan. 17, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals,
Inc. (Nasdaq:ACHN) announced today that Joseph Truitt, Senior Vice President
of Business Development and Chief Commercial Officer of Achillion, will
present a corporate update at the upcoming Noble Financial Capital Markets'
Ninth Annual Equity Conference on Wednesday, January 23, 2013 at 9:30 a.m. EST
at the Hard Rock Hotel in Hollywood, FL.

The live audio and video broadcast and the subsequent archived webcasts of the
Company's presentations will be available on the Company's website,
http://www.achillion.com, under the "News Center" section. The audio recording
will be archived for 30 days following the live presentation. Please connect
to Achillion's website several minutes prior to the start of the presentation
to ensure adequate time for any software downloads that may be necessary.

About Achillion Pharmaceuticals

Achillion is an innovative pharmaceutical company dedicated to bringing
important new treatments to patients with infectious disease. Achillion's
proven discovery and development teams have advanced multiple product
candidates with novel mechanisms of action. Achillion is focused on solutions
for the most challenging problems in infectious disease including the
hepatitis C virus (HCV) and resistant bacterial infections. For more
information on Achillion Pharmaceuticals, please visit www.achillion.com or
call 1-203-624-7000.

CONTACT: Company Contact:
         Glenn Schulman
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 752-5510
         gschulman@achillion.com
        
         Investors:
         Mary Kay Fenton
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         mfenton@achillion.com
 
Press spacebar to pause and continue. Press esc to stop.